Mary Barden

Exploring neurological complications of systemic cancer therapies, including chemotherapy-induced neurotoxicity, immune checkpoint inhibitors, and CAR-T cell therapy. Discussion on monitoring and managing neurotoxicity post-treatment, immune reconstitution inflammatory syndrome, and challenges in treating complications.